Quotes 5-day view  End-of-day quote Otc Markets | |
|
| 07/20/2022 |
07/22/2022 |
07/25/2022 |
07/26/2022 |
07/27/2022 |
Date |
| 0.0002 |
0.0002 |
0.0002 |
0.0002 |
0.0002 |
Last |
| 8607 |
245 |
2179 |
2420 |
6460 |
Volume |
| 0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Change |
|
|
|
| 2022 | Hikma's diversified business delivers resilient H1 performance | AQ |
| 2022 | Teligent, Inc. Went Out of Business | CI |
| 2022 | Second Amended Liquidation Plan Approved for Teligent, Inc. | CI |
| 2022 | Second Motion for Exclusivity Period Extension Approved For Teligent, Inc. | CI |
| 2022 | Second Amended Joint Liquidation Plan Filed by Teligent, Inc. | CI |
| 2022 | First Amended Disclosure Statement Approved for Teligent, Inc. | CI |
| 2022 | First Amended Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc. | CI |
| 2022 | Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc. | CI |
| 2022 | First Motion for Exclusivity Period Extension Approved For Teligent, Inc. | CI |
| 2022 | Motion for Case Conversion Filed by Teligent, Inc. | CI |
| 2022 | First Motion for Exclusivity Period Extension Filed by Teligent, Inc. | CI |
| 2022 | Hikma Pharmaceuticals Closes $46 Million Purchase of Teligent's Canadian Assets | MT |
| 2022 | Pharmaceutical Associates, Inc. completed the acqui.. | CI |
| 2022 | Hikma Pharmaceuticals PLC completed the acquisition.. | CI |
| 2022 | Motion for Asset Sale Approved for Teligent, Inc. | CI |
| |
|
| News in other languages on TELIGENT |
|
|
| |
|
|
|
|
|
|
Duration :
Period :
|
 | |
|
|
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
